Increased Skp2 Expression in Melanoma Linked to Patient Survival
Author Information
Author(s): Chen Guangdi, Cheng Yabin, Zhang Zhizhong, Martinka Magdalena, Li Gang
Primary Institution: University of British Columbia
Hypothesis
The study investigates the role of Skp2 expression in melanoma development and its correlation with patient survival.
Conclusion
Cytoplasmic Skp2 expression is associated with poor survival outcomes in primary melanoma patients.
Supporting Evidence
- Cytoplasmic Skp2 expression increased from normal nevi to metastatic melanomas.
- High cytoplasmic Skp2 expression correlated with poor five-year disease-specific survival.
- No significant correlation was found between nuclear Skp2 expression and patient survival.
Takeaway
This study found that higher levels of a protein called Skp2 in melanoma patients can mean they might not live as long.
Methodology
The study used tissue microarrays and immunohistochemistry to assess Skp2 expression in various stages of melanocytic lesions.
Potential Biases
Potential biases in patient selection and retrospective analysis of survival data.
Limitations
The study may not account for all variables affecting patient survival, and the correlation does not imply causation.
Participant Demographics
The study included 436 melanoma patients, with a median age of 60 years, comprising 258 men and 178 women.
Statistical Information
P-Value
P<0.001 for AJCC stages correlation
Confidence Interval
95% CI for hazard ratios reported in the study
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website